Waiting for chest X-rays or lab results to diagnose pneumonia and other lung-related diseases may not be necessary in the ...

According to MarketsandMarkets™, the Digital Biomarkers Market is projected to grow from about USD 7.41 billion in 2026 to USD 17.73 billion by 2031, at a CAGR of 19.1%.

The biomarker data presented at AD/PD 2026 from the Phase III APOLLOE4 trial showed that in the MCI subgroup, valiltramiprosate treatment resulted in a significant reduction in plasma p-tau217.

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...

The world’s largest professional psychiatry organization is preparing for the day when biological indicators can help ...

Presented by Voice Biota What if your voice could help detect changes in your health? That’s the idea behind an emerging ...

The study showed statistically significant improvements (p<0.05) across 43 biomarkers, including LDL cholesterol, HbA1c, and vitamin D, in a cohort of over 20,000 users. -- Proven Engagement and ...

Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other related disorders, represent a ...

Microscopic sensors that are as thin as a strand of hair but capable of taking multiple measurements simultaneously could revolutionize the diagnosis and monitoring of diseases like cancer.